Is ACAD or ACHV more undervalued in 2026?

CirclFi compares ACADIA Pharmaceuticals Inc. (ACAD) and Achieve Life Sciences, Inc. (ACHV) using 13 institutional-grade valuation models. ACAD has a Quality of Company score of 9.4/10 while ACHV scores 4.3/10.

Which is a better buy — ACAD or ACHV?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do ACAD and ACHV valuations compare?

ACAD at $21.63 and ACHV at $5.30 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

ACAD vs ACHV Valuation Comparison 2026 — Intrinsic Value Analysis

ACAD

Biotechnology

ACADIA Pharmaceuticals Inc.

Quality

9.4

out of 10

Value Trap

SAFE

Price

$21.63

Last close

Models

13/13

Active

ACHV

Biotechnology

Achieve Life Sciences, Inc.

Quality

4.3

out of 10

Value Trap

LOW

Price

$5.30

Last close

Models

7/13

Active

Model-by-Model Comparison

Model	Type	ACAD Fair Value	ACAD Upside	ACHV Fair Value	ACHV Upside
Bayesian DCF	Intrinsic	$22.90	+5.9%	$1.57	-70.5%
Earnings Power Value	Intrinsic	$3.82	-82.3%	—	—
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
Markov DDM	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$5.84	-73.0%	$0.41	-92.3%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for ACAD vs ACHV — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

ACAD vs ACHV — Which Stock Is More Undervalued?

ACAD scores higher with a 9.4/10 quality rating vs ACHV's 4.3/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing ACADIA Pharmaceuticals Inc. (ACAD) and Achieve Life Sciences, Inc. (ACHV) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

ACAD currently trades at $21.63 with a QOC of 9.4/10, while ACHV trades at $5.30 with a QOC of 4.3/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).